Correlation Between GlaxoSmithKline PLC and IShares MSCI
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and IShares MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and IShares MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and iShares MSCI Pacific, you can compare the effects of market volatilities on GlaxoSmithKline PLC and IShares MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of IShares MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and IShares MSCI.
Diversification Opportunities for GlaxoSmithKline PLC and IShares MSCI
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between GlaxoSmithKline and IShares is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and iShares MSCI Pacific in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares MSCI Pacific and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with IShares MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares MSCI Pacific has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and IShares MSCI go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and IShares MSCI
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the IShares MSCI. In addition to that, GlaxoSmithKline PLC is 1.36 times more volatile than iShares MSCI Pacific. It trades about -0.3 of its total potential returns per unit of risk. iShares MSCI Pacific is currently generating about 0.03 per unit of volatility. If you would invest 4,699 in iShares MSCI Pacific on August 28, 2024 and sell it today you would earn a total of 24.00 from holding iShares MSCI Pacific or generate 0.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. iShares MSCI Pacific
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| iShares MSCI Pacific |
GlaxoSmithKline PLC and IShares MSCI Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and IShares MSCI
The main advantage of trading using opposite GlaxoSmithKline PLC and IShares MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, IShares MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares MSCI will offset losses from the drop in IShares MSCI's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| IShares MSCI vs. Matthews China Active | IShares MSCI vs. MAYBANK EMERGING ETF | IShares MSCI vs. Matthews Emerging Markets | IShares MSCI vs. JP Morgan Exchange Traded |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |